NCT03927053 is a clinical trial in Youth With HIV, sponsored by Duke University.

Who is sponsoring NCT03927053?

NCT03927053 is sponsored by Duke University.

What condition does NCT03927053 study?

NCT03927053 studies Youth With HIV.

Is NCT03927053 still recruiting?

NCT03927053 is currently completed. Last updated 13 November 2023.

Last reviewed 2023-11-13 · How we verify

NCT03927053

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Consequences of Marijuana Use in HIV-infected Youth

Completed Last updated 13 November 2023

What this trial tests

trial in Youth With HIV in 21 participants. Completed in 15 October 2021.

Timeline

31 October 2019

Primary endpoint
15 October 2021

15 October 2021

Quick facts

Lead sponsor	Duke University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	21
Start date	31 October 2019
Primary completion	15 October 2021
Estimated completion	15 October 2021
Sites	2 locations across United States

Conditions studied

Youth With HIV — all drugs for Youth With HIV →

Sponsor

Duke University

Who can join

Adults 21 to 28, any sex, with Youth With HIV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Proposed study focuses on Youth With HIV (YWH) recruited from the University of North Carolina using a cross sectional assessment of blood samples, clinical, demographic, behavioral, \[including substance use and frequency\], and neurocognitive data will be evaluated from YWH treated before CD4 T cell decline.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Multi-Modal Profiling Reveals Contrasting Immunomodulatory Effects of Recreational Marijuana Used Alone or with Tobacco in Youth with HIV.
Borkar SA, Venturi GM, Chang KF, Gu J, et al · · 2025 · PMID 40862746 · DOI 10.3390/cells14161267

Verify or expand the search:

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03927053 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 13 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03927053.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing